Floatz logo

Therapeutic Asset Ratings

766 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[111in]-fpi-1967
Colorectal Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[111in]-fpi-1967
Ovarian Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[ 161 tb]tb psma i&t
Prostate Cancer
Peter MacCallum Cancer Centre, AustraliaP1/2CC (40)
177lu-betabart
Colorectal Cancer
Radiopharm Theranostics, LtdP1/2CC (40)
177lu-betabart
Ovarian Cancer
Radiopharm Theranostics, LtdP1/2CC (40)
177lu-fap-2286
Neoplasm
Novartis PharmaceuticalsP1/2CC (40)
[177lu]lu-sn201
Neoplasm
Spago Nanomedical ABP1/2CC (40)
[177Lu] Lu-XT033
Prostate Cancer
Sinotau Pharmaceutical GroupP1/2CC (40)
[18f]f-resca-rt4
Breast Cancer
RenJi HospitalP1/2CC (40)
[203pb]pb-psv359
Colorectal Cancer
Perspective TherapeuticsP1/2CC (40)
[203pb]pb-psv359
Ovarian Cancer
Perspective TherapeuticsP1/2CC (40)
[²¹²pb]pb-advc001
Prostate Cancer
AdvanCell Pty LimitedP1/2CC (40)
[212pb]pb-psv359
Colorectal Cancer
Perspective TherapeuticsP1/2CC (40)
[212pb]pb-psv359
Ovarian Cancer
Perspective TherapeuticsP1/2CC (40)
[225Ac]-FPI-1966
Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[225Ac]-FPI-1966
Breast Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[225Ac]-FPI-1966
Colorectal Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
[225Ac]-FPI-1966
Ovarian Cancer
Fusion Pharmaceuticals Inc.P1/2CC (40)
225ac-lnc1011
Prostate Cancer
First Affiliated Hospital of Fujian Medical UniversityP1/2CC (40)
64cu-grip b
Cancer
Rahul AggarwalP1/2CC (40)
64cu-grip b
Prostate Cancer
Rahul AggarwalP1/2CC (40)
64cu-lnth-1363s
Colorectal Cancer
Lantheus Medical ImagingP1/2CC (40)
64cu-lnth-1363s
Pancreatic Neoplasm
Lantheus Medical ImagingP1/2CC (40)
aaa602
Prostate Cancer
Novartis PharmaceuticalsP1/2CC (40)
aaa802
Prostate Cancer
Novartis PharmaceuticalsP1/2CC (40)
Showing 376 to 400 of 766 assets
PreviousPage 16 of 31Next